About 2 Trademarks found for “NPOD*”

Electronic cigarettes; cases for electronic cigarettes; cases for electronic cigarette accessories; cartridges sold filled with chemical flavorings in liquid or gel form for electronic cigarettes; cigarettes; cigars; smokers' mouthpieces for electronic cigarettes; chemical flavourings in liquid form used to refill electronic cigarette cartridges; liquid nicotine solutions for use in electronic cigarettes; liquid solutions for use in electronic cigarettes; electronic cigarette gel containing nicotine; electronic cigarette liquid solutions containing nicotine; flavourings, other than essential oils, for use in electronic cigarettes; electronic cigarette atomizers; electronic cigarette cartomizers; nicotine-free electronic cigarette liquid comprised of flavorings in liquid form, other than essential oils; tobacco vaporizers; ampoules for electronic cigarettes; cartridges for electronic cigarettes; refill cartridges for electronic cigarettes; electronic vaporizers as an alternative to cigarettes; electronic cigarette boxes; inhalers for use as an alternative to tobacco cigarettes; oral vaporizers for smokers; smokeless cigarette vaporizer pipes; smoking sets for electronic cigarettes; flavorings, other than essential oils, for tobacco substitutes; electronic cigarette cases; electronic cigarette racks; e-cigarette flavourings sold in pods, other than essential oils; electronic cigarette holders; parts and fittings for all the aforesaid goods.

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for the use in the treatment of attention deficit disorders, central nervous systems disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders , hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis.

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations.